Stock Info Nets

Independent Financial Information Made Easy

Our AI creates

The Best Stock Graphs and Charts

Youtube Subscribe Blog GamificArt

The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.

General Description

Inhibikase Therapeutics

Youtube Subscribe

...

Ticker: IKT

Sector: Biotechnology

Inhibikase Therapeutics, Inc. develops therapeutics for Parkinson's disease and related disorders. Its lead product candidate is IkT-148009, a small molecule Abelson tyrosine kinase inhibitor. IkT.
...
...
Extended Summary

Inhibikase Therapeutics

Inhibikase Therapeutics, Inc., a clinical-stage pharmaceutical company, develops therapeutics for Parkinson's disease and related disorders. Its lead product candidate is IkT-148009, a small molecule Abelson tyrosine kinase inhibitor, which is in Phase 2a clinical trials to the treatment of Parkinson's disease and gastrointestinal tract. The company is also developing IkT-001Pro, a prodrug of the anticancer agent imatinib mesylate to treat stable phase chronic myelogenous leukemia. Inhibikase Therapeutics, Inc. has research and development collaborations with Johns Hopkins University, Arizona State University, University of Bordeaux, and Michigan State University, as well as University of California; and a collaborative research and development agreement with Sphaera Pharma Pte. Ltd. The company was founded in 2008 and is headquartered in Atlanta, Georgia.

Related Results

...
November 15, 2023 1:44 (London Time)

Inhibikase Therapeutics

Analysts estimate Inhibikase Therapeutics will report an earnings per share (EPS) of $-1.19. Shares of IKT were trading at $1.0 as of November 10. I…
Sector: Biotechnology
Ticker: IKT
Sentiment: 0.4767
MarketCap: 5,013,520.0
High: 1.0 Low: 0.92

Open: 1.0 Close: 0.98 Change: -0.02

Read more →
...
April 19, 2023 15:28 (London Time)

Inhibikase Therapeutics

Inhibikase Therapeutics has a one year low of $0.44 and one year high of $1.34. Several large investors have recently bought and sold shares. Inhibi…
Sector: Biotechnology
Ticker: IKT
Sentiment: 0.7424
MarketCap: 16,676,379
High: 0.58 Low: 0.56

Open: 0.57 Close: 0.58 Change: 0.01

Read more →
Search
Happening Now
Categories